Follow the Kane Biotech Inc. share price and the full insider trade history of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the supervision of SEDI. Operating in the Health Care sector, Kane Biotech Inc. has published 16 reports. Market capitalisation: €6.2m. The latest transaction was reported on 6 July 2026 (50 - Grant of options). Among the most active insiders: Renaud, Philip. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.